
Juvenescence enhances AI drug discovery with Ro5 acquisition
Juvenescence has acquired drug discovery company Ro5, a move that enhances its AI/machine learning capabilities and improves research and development capabilities. The acquisition forms a key part of Juvenescence’s partnership with the Abu Dhabi global …